Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Deep Genomics will use the money to advance drug candidates created through its AI drug development model, based on research by Toronto faculty.

Lilly Asia Ventures took part in a series B-plus round that marks the first for biopharmaceutical company Transcenta Holding, formed through the merger of two of the corporate's portfolio companies.

WuXi AppTec and New World Development-backed Adagene has now raised $155m in total, as it takes its first cancer immunotherapy through clinical testing.

Bloomberg Beta-backed Deep Genomics will use the series B funding to advance drug candidates created through its artificial intelligence drug development model.

The medical data analytics platform has raised $5m from Merck Global Health Innovation Fund, adding to $23m raised last year.

Alexandria Venture Investments has helped UW's genetic sequencing technology developer TwinStand raise series A financing.

Existing investor Alexandria Venture Investments has helped genetic sequencing technology developer TwinStand increase its overall funding to $21.5m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Galecto, based on research at Lund and Edinburgh universities, is merging with PharmAkea, with the joint entity retaining the Galecto name and leadership team.